Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

by Okusaka, Takuji, Aramaki, Takeshi, Inaba, Yoshitaka, Nakamura, Shinichiro, Morimoto, Manabu, Moriguchi, Michihisa, Sato, Takashi, Ikawa, Yuta, Ikeda, Masafumi, Furuse, Junji
Published 2015

Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced...

by Takada, Juichi, Hidaka, Hisashi, Nakazawa, Takahide, Kondo, Masaaki, Numata, Kazushi, Tanaka, Katsuaki, Matsunaga, Kotaro, Okuse, Chiaki, Kobayashi, Satoshi, Morimoto, Manabu, Ohkawa, Shinichi, Koizumi, Wasaburo
Published 2015

High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomas

by Fukuda, Hiroyuki, Numata, Kazushi, Nozaki, Akito, Kondo, Masaaki, Morimoto, Manabu, Maeda, Shin, Tanaka, Katsuaki, Ohto, Masao, Ito, Ryu, Ishibashi, Yoshiharu, Oshima, Noriyoshi, Ito, Ayao, Zhu, Hui, Wang, Zhi-Biao
Published 2013

The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas

by Murakawa, Masaaki, Aoyama, Toru, Asari, Masahiro, Katayama, Yusuke, Yamaoku, Koichiro, Kanazawa, Amane, Higuchi, Akio, Shiozawa, Manabu, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Yamamoto, Naoto, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Published 2015

Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese

by Ueno, Makoto, Ohkawa, Shinichi, Morimoto, Manabu, Ishii, Hiroshi, Matsuyama, Masato, Kuruma, Sawako, Egawa, Naoto, Nakao, Haruhisa, Mori, Mitsuru, Matsuo, Keitaro, Hosono, Satoyo, Nojima, Masanori, Wakai, Kenji, Nakamura, Kozue, Tamakoshi, Akiko, Takahashi, Mami, Shimada, Kazuaki, Nishiyama, Takeshi, Kikuchi, Shogo, Lin, Yingsong
Published 2015